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caused by Actinomyces meyeri, an unknown cause
of septic shock
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Thierry Landois2, Charlie Frédéric Ouaki3 and Olivier Lesieur1Abstract
The objective of this case report is to describe the first case of renal actinomycosis caused by Actinomyces meyeri
presenting as severe emphysematous pyelonephritis and complicated by septic shock and multi-organ failure.
Emphysematous pyelonephritis is a potentially life-threatening infection mostly described in diabetic patients and
predominantly caused by uropathogenic bacteria. Actinomycosis is an uncommon chronic infection due to
anaerobic gram-positive bacteria that unusually involves the urinary tract. We report the first case of emphysematous
pyelonephritis caused by A. meyeri in a 75-year-old non-diabetic woman. The patient presented with an altered status,
fever, nausea, and vomiting lasting for 2 days. A computed tomography scan revealed unilateral emphysematous
pyelonephritis. She was rapidly admitted to intensive care unit for a septic shock with multiple organ dysfunctions.
A conservative management consisting in renal percutaneous drainage, supportive measures, and prolonged
adapted antibiotic therapy resulted in complete recovery. This case report illustrates that renal actinomycosis
should be considered in case of emphysematous pyelonephritis given the good prognosis of this infection with
conservative medical treatment.
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Emphysematous pyelonephritis (EPN) is a potentially life-
threatening disease characterized by a severe necrosis of
the renal parenchyma with presence of gas in the renal
parenchyma, collecting system, and/or perinephric tissue.
Escherichia coli is the commonest causative organism
found for about 70% of cases. Other organisms like
Proteus, Pseudomonas, Klebsiella, and Acinetobacter
can also be found [1]. Actinomycosis is an uncommon
chronic infection due to a gram-positive anaerobic bacter-
ium. Actinomyces israelii is the most common human
pathogen among all Actinomyces pathogenic species. The
cervicofacial area, pelvic region, and thoracic involvement
are the most common clinical presentations, but very few* Correspondence: alexandre.herbland@orange.fr
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unless otherwise stated.cases of renal actinomycosis (RA) are reported. Our
literature review uncovered only one prior report of
EPN revealing a RA after nephrectomy [2]. We report
the first case of RA with Actinomyces meyeri in urine cul-
tures presenting as an EPN complicated by a septic shock
and successfully treated with conservative management.
Case presentation
A 75-year-old female presented to a local clinic with a
history of fever, nausea, vomiting, and anorexia lasting
for 2 days. Medical history was significant only for arterial
hypertension, obesity (body mass index 29), and urinary
incontinence. She was treated by oral antihypertensive
therapy and solifenacin for her overactive bladder.
Physical examination revealed fever with body tem-
perature of 101.3°F (38.5°C), tachypnea with respiratory
rate of 25 breaths/min, normal hemodynamic parameters
with blood pressure 125/57 mmHg, and pulse 80 beats/al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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matory process and moderate renal impairment. The
white blood cell count was 37.6 × 109/L with neutro-
phils 85%. Hemoglobin was 100.2 g/L. The platelet count
was normal 263 × 109/L, and fibrinogen was 32.89 μmol/L.
C-reactive protein was 591 mg/L; the serum gamma-
glutamyltransferases level was increased up to 276 U/L.
The alkaline phosphatases level was 168 U/L. The bili-
rubin was 9.7 μmol/L. The urea nitrogen and creatinine
serum levels were, respectively, 18 mmol/L and 282 μmol/L.
The other laboratory tests for blood chemistry panel and
liver function were normal. Few minutes after her admis-
sion, the patient's blood pressure dropped dramatically
with anuria and hypoxemia, so she received oxygen ther-
apy (10 L/min with a reservoir mask) and intravenous
fluid therapy with 1,500 mL of crystalloid (Ringer lactate)
and 500 mL of colloid (6% hydroxyethyl starch 130/0.4).
Urgent abdominal computed tomography (CT) scan
permitted the diagnosis of EPN showing a pyonephrosis
of the right kidney and presence of pneumaturia in the
collecting system and in a cyst located in the lower pole
of the right kidney (Figure 1). The pelvi-caliceal cavities
of the right kidney appeared slightly dilated. After blood
cultures, intravenous antibiotic therapy was initiated with
amoxicillin/clavulanic acid 1 g and ofloxacin 200 mg.
Despite antibiotic therapy and supportive measures, the
patient's clinical condition rapidly deteriorated towards
a septic shock with multiple organ dysfunction syn-
drome. The patient required mechanical ventilator sup-
port and intravenous vasopressor (norepinephrine). She
was promptly transferred to our hospital to undergo
urgent ureteral stenting.
On admission to the operating room, protective venti-
lation settings (controlled mandatory ventilation, tidal
volume of 7 mL/kg of predicted body weight, respira-
tory rate 20 breaths/min, FiO2 1.0) resulted in a PaO2/
FiO2 ratio at 122. Hemodynamic parameters withFigure 1 Emphysematous pyelonephritis (EPN) of the right kidney. Co
enlarged right kidney and normal left kidney. Gas is present in the renal pe
right kidney (white arrows). There is also significant perirenal infiltration (blucontinuous intravenous norepinephrine 0.4 gamma/kg/
min showed pulse 90 beats/min and mean arterial pres-
sure 69 mmHg, and the patient was still anuric. A right
retrograde cystoscopic pyelogram revealed a moderate
pelvi-caliceal dilatation and also allowed a right ureteral
open-ended stenting with drainage of a pyuria.
The patient was subsequently admitted to our ICU.
Antibiotics were switched to intravenous ceftriaxone
(2 g/day) plus ofloxacin (200 mg twice a day) and metro-
nidazole (500 mg every 8 h). Septic shock improved in
the following 2 days. Her renal function recovered with-
out need of renal replacement therapy and with equal
diuresis of both kidneys. Despite improvement of the
patient's condition, we observed a reascension of WBC
at day 3 (50 × 109/L). Gynecological examination with
hysteroscopy excluded genital infection. CT scan showed
a persistent posterior abscess of the right kidney with
inflammatory infiltration of the perirenal space. After
discussion with urologists and radiologists, a percutan-
eous CT scan-guided drainage was performed by a radi-
ologist who placed a stent in the abscess and collected a
hemic and purulent fluid. The patient's condition rapidly
improved, so she was extubated on day 8. On day 11, the
CT scan-guided drainage was complicated by a fistula,
with the urinary tract successfully treated by a double J
stenting of the right ureter.
Microscopic examination of urine collected by cystos-
copy from the right pelvi-caliceal cavity showed presence
of pyuria, Gram stain detected gram-positive bacilli, and
culture was positive with A. meyeri 105 CFU/mL with the
use of Vitek 2 ANC card (bioMérieux, Marcy l'Etoile,
France). Antibiotherapy was finally switched to amoxicillin
2 g × 3 per day according to the antibiogram for a duration
of 3 months against A. meyeri. As advised by our in-
fectious disease specialists, ofloxacin (200 mg twice a
day) was maintained for 21 days covering a hypothetic
non-diagnosed coinfection with gram-negative bacilli.mputed tomography scan demonstrates right-sided EPN with
lvis, in the proximal ureter (red arrows), and in a posterior cyst of the
e arrows).
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tion of A. meyeri. At day 10, the patient was finally
discharged from the ICU to the department of urology
in stable condition. She recovered a normal renal
function and was transferred back to her home at day
24. She underwent an abdominal CT scan 2 months
later (Figure 2) showing regression of the right pyone-
phrosis with normal parenchyma, no dilatation, and
persistence of a right renal cyst of reduced diameter.
Four months later, ureteroscopic examination revealed
no abnormality and double J stenting was retrieved.
Discussion
EPN is a renal infection caused predominantly by gram-
negative rods which are capable of fermenting glucose in
an anaerobic environment [3]. E. coli is the commonest
organism found in about 75% of patients with EPN;
other organisms like Klebsiella and Proteus are also re-
ported [1]. EPN caused by various fungi like Candida
and Aspergillus fumigatus are also sporadically documented
[4-6]. EPN predominantly concerns women (female/male
ratio is 6:1) and can be unilateral or bilateral [1,7,8].
Around 95% of patients developing EPN have uncon-
trolled diabetes mellitus (DM), but other associated
factors are reported as drug abuse, neurogenic bladder,
alcoholism, immune-compromised status, anatomical
anomaly, or presence of urinary tract obstruction
[1,7-10]. In our case, DM was not present, but the pa-
tient had two associated risks for EPN: urinary incon-
tinence and a cyst on the right kidney, an anatomical
particularity which may have induced local urine reten-
tion with moderate obstruction of the pelvi-caliceal
cavities.
Diagnosis was made by CT scan which is currently
the radiographic method of choice both for diagnosing
EPN and demonstrating the extent of the disease [1].
Sonographic diagnosis of EPN is also possible by theFigure 2 The 2-month follow-up computed tomography scan. The foll
complete absence of gas in the right kidney. A small posterior cyst of the r
disappeared (blue arrows).recognition of echogenic foci with ‘dirty’ shadowing in
a non-dependent position, highly suggestive of gas
inside the kidney [11]. Ultrasonography can also be
useful to realize guided percutaneous drainage of renal
abscesses. But the presence of gas within the renal par-
enchyma in EPN produces artifactual reverberation
echoes, compromising the quality of the ultrasound
images. Thus, we opted for CT scan-guided percutan-
eous drainage of the renal abscess. Moreover, CT scan
allows much more accuracy than ultrasonography for
the drain placement because the entire guidewire or
drainage catheter is usually demonstrated more clearly
by CT than by ultrasound. In patients with EPN, beside
aggressive medical management (prompt appropriate
antibiotics and resuscitation measures with multi-organ
support), percutaneous drainage seems to be the most
successful management compared with medical man-
agement alone or plus nephrectomy with the lowest
mortality at 13.5% (P < 0.001) [12].
Actinomycosis is a rare chronic infection due to an-
aerobic gram-positive bacteria that unlikely involves the
urinary tract [13-15]. This infection is due to a group of
bacteria which are normal commensals found in the
mouth and gastrointestinal tract, with A. israelii being
the most common agent identified in human infections
and particularly in RA. It seems that Actinomyces are
able to invade mucous membranes under certain cir-
cumstances such as mucosal alteration secondary to
trauma or infection by other organisms [16]. Poor hy-
giene, underlying diseases, or immunosuppression can
be found in patients with actinomycosis, but pre-
disposing factors are not systematically documented
[17]. In our case, it is still unclear how the patient
contracted the infection, as there was neither history
of previous surgical treatment nor other risk factors
identified. Hematogenous origin can be hypothesized
without certainty.ow-up computed tomography scan shows the normalizing size and
ight kidney is still present (red arrow). Perirenal infiltration has almost
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http://www.jintensivecare.com/content/2/1/42Actinomyces meyeri was first isolated from a patient
with a lung empyema by Meyer in 1911, who termed it
Streptothrix. The nomenclature was changed to Actino-
bacterium meyerii by Prevot in 1956 and subsequently
to Actinomyces meyeri by Holderman in 1977 [18]. A re-
cent review of the literature revealed only 32 documented
cases of infection with A. meyeri [19]. According to this
article, 13 patients had a disseminated disease, and the
most frequent sites of infection were pulmonary, gastro-
intestinal, skin, and soft tissues, respectively. No case of
urinary tract infection was reported.
The few cases of RA published are characterized by a
medical presentation mimicking malignancy with pseudo-
tumoral aspect, insidious course, and non-specific symp-
toms [20-22]. The diagnosis is difficult, and only few
patients have avoided nephrectomy or at least surgical
exploration. Diagnosis can be made by ultrasound or
CT-guided fine needle biopsy [23,24]. In our particular
case, microbiological diagnosis of actinomycosis was
based on concordant Gram stain result (gram-positive
bacilli) and positive urine culture collected in the upper
urinary tract under ureteroscopy. As we opted for a
non-invasive treatment, we did not perform any biopsy
for histological examination. Furthermore, other urine
and blood cultures (including those taken before first
antibiotherapy) failed to grow any other microorganism.
A case of RA presenting as EPN and complicated by
septic shock was already reported from Taiwan [2]. The
patient recovered after medical treatment and nephrec-
tomy. Diagnostic of RA was made on histological exam-
ination of the surgical kidney and ureteral specimens.
Microbiological identification of Actinomyces species is
not detailed in the article, and the patient had a urinary
tract coinfection with E. coli that could explain such an
emphysematous presentation. Our search for published
literature did not reveal any report of urinary tract infec-
tion or EPN caused by A. meyeri.
Actinomyces are usually susceptible to a wide variety
of antimicrobial agents including penicillin G, cephalospo-
rins, tetracycline, erythromycin, clindamycin, imipenem,
and streptomycin [25,26] but are resistant to fluoroquino-
lones which are widely prescribed for urinary tract infec-
tions. There is no consensus recommendation for medical
treatment of RA and no particular sensitivity or resistance
to antibiotics identified for A. meyeri given the small num-
ber of cases reported [19]. Clinical experience supports
the use of intravenous penicillin G as the drug of choice
(18 to 24 million U/day) for 2 to 6 weeks followed by oral
therapy. For other Actinomyces infections, a prolonged
duration of antibiotic therapy is advised to avoid relapse
varying to 2 months for the localized disease to 12 months
for more extensive and disseminated disease [26]. The
treatment needs to be individualized based on the clinical
and radiological response.Conclusions
RA is a rare and difficult infection to recognize and
should be considered of etiological diagnosis for EPN.
This first case report of severe EPN secondary to RA
caused by A. meyeri clearly illustrates that EPN is a
potentially life-threatening disease. A CT scan-guided
percutaneous drainage of renal abscess was a safe and
effective procedure which permitted decisive improve-
ment of the patient's condition. Awareness of this entity
may encourage physicians to make the diagnosis and
to implement effective long-lasting antibiotic therapy,
avoiding futile surgery and preserving further renal
function.Consent
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